<?xml version="1.0"?>
  <rss version="2.0">
    <channel>
      <title>Bisoprolol and Hydrochlorothiazide News : GoldBamboo.com</title>
      <link>http://goldbamboo.com/</link>
      <description>Bisoprolol and Hydrochlorothiazide News from GoldBamboo.com</description>
      <language>en-us</language>
      <copyright>&amp;copy; 2005, Gold Bamboo LLC, All Rights Reserved</copyright>
      
	<item>
        <title>Lupin Receives Final Approval For Lisinopril-HCTZ Tablets</title>
        <link>http://goldbamboo.com/news-a200579.html</link>
        <description>Lupin Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted final approval for its Abbreviated New Drug Application (ANDA) for Lisinopril and Hydrochlorothiazide tablets in 10mg/12.5mg, 20mg/12.5mg and 20mg/25mg strengths.     Lupin's Lisinopril-HCTZ tablets are the AB-rated generic equivalent of Prinzide(R) Tablets of Merck &amp; Co., Inc. [click link for full article]</description>
		 <pubDate>Fri, 29 Sep 2006 07:00 EST</pubDate>
	</item>
	<item>
        <title>FDA Approves Higher Dose Formulations Of Diovan HCT(R) (valsartan/hydrochlorothiazide) For Treatment Of High Blood Pressure</title>
        <link>http://goldbamboo.com/news-a178358.html</link>
        <description>The U.S. Food and DrugAdministration (FDA) approved two new, higher dose formulations of the highblood pressure medication Diovan HCT(R) (valsartan/hydrochlorothiazide):320/12.5 mg and 320/25 mg. The approval of the higher strengths of DiovanHCT provides more options to help physicians more effectively manage theirpatients' high blood pressure... click link for more info.</description>
		 <pubDate>Tue, 02 May 2006 06:00 EST</pubDate>
	</item>
	<item>
        <title>Benefits of starting CHF treatment with beta-blocker</title>
        <link>http://goldbamboo.com/news-a148699.html</link>
        <description>Initiating treatment with the selective beta-blocker, bisoprolol, is as effective and well tolerated as beginning treatment with an ACE inhibitor... click link for more info.</description>
		 <pubDate>Mon, 05 Sep 2005 11:00 EST</pubDate>
	</item>
	<item>
        <title>Benicar and Benicar HCT significantly reduces systolic hypertension, study</title>
        <link>http://goldbamboo.com/news-a131286.html</link>
        <description>Data from two clinical studies presented at the American Society of Hypertension''s Twentieth Annual Scientific Meeting (ASH 2005) in San Francisco demonstrated that BENICAR® (olmesartan medoxomil) and BENICAR HCT® (olmesartan medoxomil/hydrochlorothiazide) were effective in treating the difficult patient with Stage 2** hypertension, as well as the less complicated Stage 1** patient, helping both achieve nationally recognized blood pressure goals... click link for more info.</description>
		 <pubDate>Fri, 27 May 2005 06:00 EST</pubDate>
	</item>
	<item>
        <title>FDA Approves HYZAAR® as First/Only Fixed-Dose Combination Hypertension Medicine to Help Prevent Stroke in Patients</title>
        <link>http://goldbamboo.com/news-a128741.html</link>
        <description>Merck &amp; Co, Inc announced that the US Food and Drug Administration (FDA) has approved another new indication for HYZAAR®, Merck's fixed-dose combination antihypertensive drug (losartan potassium-hydrochlorothiazide tablets)... click link for more info.</description>
		 <pubDate>Sun, 15 May 2005 07:00 EST</pubDate>
	</item>
	

    </channel>
  </rss>
